Company Filing History:
Years Active: 2025
Title: Cristina Tognon: Innovator in Acute Myeloid Leukemia Treatments
Introduction
Cristina Tognon is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of medicine, particularly in the treatment of acute myeloid leukemia (AML). Her innovative work focuses on developing methods to treat AML in the presence of gene mutations.
Latest Patents
Cristina holds a patent for her invention titled "Treatments for mutations in acute myeloid leukemia." This patent outlines useful methods for treating AML in humans, specifically targeting cases where gene mutations are present. She has been recognized for her groundbreaking approach to this challenging medical condition.
Career Highlights
Cristina Tognon is affiliated with Oregon Health & Science University, where she conducts her research and develops her innovative treatments. Her work has garnered attention in the medical community, and she continues to push the boundaries of cancer treatment.
Collaborations
Cristina collaborates with esteemed colleagues, including Jeffrey Tyner and Brian Jay Druker. Their combined expertise enhances the research and development of effective treatments for AML.
Conclusion
Cristina Tognon's contributions to the field of acute myeloid leukemia treatment exemplify her dedication to medical innovation. Her work not only advances scientific understanding but also offers hope to patients facing this challenging disease.